Causes of Death in Elderly Patients With Non-Valvular Atrial Fibrillation ― Results From the ANAFIE Registry

Background: Previous studies on mortality in atrial fibrillation (AF) included a limited number of elderly patients receiving direct oral anticoagulants (DOACs). This subanalysis of the ANAFIE Registry evaluated 2-year mortality according to causes of death of elderly non-valvular AF (NVAF) patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation Journal 2023/06/23, Vol.87(7), pp.957-963
Hauptverfasser: Yamashita, Takeshi, Akao, Masaharu, Atarashi, Hirotsugu, Ikeda, Takanori, Koretsune, Yukihiro, Okumura, Ken, Shimizu, Wataru, Suzuki, Shinya, Tsutsui, Hiroyuki, Toyoda, Kazunori, Hirayama, Atsushi, Yasaka, Masahiro, Yamaguchi, Takenori, Teramukai, Satoshi, Kimura, Tetsuya, Morishima, Yoshiyuki, Takita, Atsushi, Inoue, Hiroshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 963
container_issue 7
container_start_page 957
container_title Circulation Journal
container_volume 87
creator Yamashita, Takeshi
Akao, Masaharu
Atarashi, Hirotsugu
Ikeda, Takanori
Koretsune, Yukihiro
Okumura, Ken
Shimizu, Wataru
Suzuki, Shinya
Tsutsui, Hiroyuki
Toyoda, Kazunori
Hirayama, Atsushi
Yasaka, Masahiro
Yamaguchi, Takenori
Teramukai, Satoshi
Kimura, Tetsuya
Morishima, Yoshiyuki
Takita, Atsushi
Inoue, Hiroshi
description Background: Previous studies on mortality in atrial fibrillation (AF) included a limited number of elderly patients receiving direct oral anticoagulants (DOACs). This subanalysis of the ANAFIE Registry evaluated 2-year mortality according to causes of death of elderly non-valvular AF (NVAF) patients in the DOAC era.Methods and Results: The ANAFIE Registry was a multicenter prospective observational study. Mean patient age was 81.5 years and 57.3% of patients were male. Of the 32,275 patients completing the study, 2,242 died. The most frequent causes of death were cardiovascular (CV) death (32.4%), followed by infection (17.1%) and malignancy (16.1%). Incidence rates of CV-, malignancy-, and infection-related death were 1.20, 0.60, and 0.63 per 100 person-years, respectively. Patients aged ≥85 years showed increased proportions of non-CV and non-malignancy deaths and a decreased proportion of malignancy deaths compared with patients aged
doi_str_mv 10.1253/circj.CJ-22-0614
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2767168561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2767168561</sourcerecordid><originalsourceid>FETCH-LOGICAL-c494t-f33292329ae216fd7f9087447d82f11fb1916f92be1933506678e2cbcaee76693</originalsourceid><addsrcrecordid>eNpFkM1O3DAUhS3UCiiwZ1V52U2ofxI7Xo7ChB8hWlWlXVpO5obxyJMMtoM0u3kJXrB9kXqYKSyur3X8nSPrIHROyQVlBf_aWt8uLqrbjLGMCJofoGPKc5nlJSMfXu8iU2XOj9CnEBaEMEUKdYiOuBAFp0weo1VlxgABDx2-BBPn2PZ46mbg3Rp_N9FCHwP-bdPD_dBnv4x7Hp3xeBK9NQ7XtvHWucQN_d_N5s_mBf-AMLrkqf2wxHEOeHI_qW-mSX-0Ifr1KfrYGRfgbL9P0EM9_VldZ3ffrm6qyV3W5iqPWcc5UyyNAUZFN5OdIqXMczkrWUdp11CVZMUaoIrzggghS2Bt0xoAKYTiJ-jLLnflh6cRQtRLG1pIn-1hGINmUkgqykLQhJId2vohBA-dXnm7NH6tKdHbnvVrz7q61Yzpbc_J8nmfPjZLmL0Z_hebgHoHLEI0j_AGGB9t62CfWEott8d78jswN15Dz_8BeraUTQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2767168561</pqid></control><display><type>article</type><title>Causes of Death in Elderly Patients With Non-Valvular Atrial Fibrillation ― Results From the ANAFIE Registry</title><source>MEDLINE</source><source>J-STAGE (Japan Science &amp; Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Yamashita, Takeshi ; Akao, Masaharu ; Atarashi, Hirotsugu ; Ikeda, Takanori ; Koretsune, Yukihiro ; Okumura, Ken ; Shimizu, Wataru ; Suzuki, Shinya ; Tsutsui, Hiroyuki ; Toyoda, Kazunori ; Hirayama, Atsushi ; Yasaka, Masahiro ; Yamaguchi, Takenori ; Teramukai, Satoshi ; Kimura, Tetsuya ; Morishima, Yoshiyuki ; Takita, Atsushi ; Inoue, Hiroshi</creator><creatorcontrib>Yamashita, Takeshi ; Akao, Masaharu ; Atarashi, Hirotsugu ; Ikeda, Takanori ; Koretsune, Yukihiro ; Okumura, Ken ; Shimizu, Wataru ; Suzuki, Shinya ; Tsutsui, Hiroyuki ; Toyoda, Kazunori ; Hirayama, Atsushi ; Yasaka, Masahiro ; Yamaguchi, Takenori ; Teramukai, Satoshi ; Kimura, Tetsuya ; Morishima, Yoshiyuki ; Takita, Atsushi ; Inoue, Hiroshi</creatorcontrib><description>Background: Previous studies on mortality in atrial fibrillation (AF) included a limited number of elderly patients receiving direct oral anticoagulants (DOACs). This subanalysis of the ANAFIE Registry evaluated 2-year mortality according to causes of death of elderly non-valvular AF (NVAF) patients in the DOAC era.Methods and Results: The ANAFIE Registry was a multicenter prospective observational study. Mean patient age was 81.5 years and 57.3% of patients were male. Of the 32,275 patients completing the study, 2,242 died. The most frequent causes of death were cardiovascular (CV) death (32.4%), followed by infection (17.1%) and malignancy (16.1%). Incidence rates of CV-, malignancy-, and infection-related death were 1.20, 0.60, and 0.63 per 100 person-years, respectively. Patients aged ≥85 years showed increased proportions of non-CV and non-malignancy deaths and a decreased proportion of malignancy deaths compared with patients aged &lt;85 years. The incidence of death due to congestive heart failure/cardiogenic shock, infection, and renal disease was higher in patients aged ≥85 than those aged &lt;85 years. Compared with warfarin, DOACs were associated with a significantly lower risk of death by intracranial hemorrhage, ischemic stroke, and renal disease.Conclusions: This subanalysis described the mortality according to causes of death of Japanese elderly NVAF patients in the DOAC era. Our results imply that a more holistic approach to comorbid conditions and stroke prevention are required in these patients.</description><identifier>ISSN: 1346-9843</identifier><identifier>ISSN: 1347-4820</identifier><identifier>EISSN: 1347-4820</identifier><identifier>DOI: 10.1253/circj.CJ-22-0614</identifier><identifier>PMID: 36653127</identifier><language>eng</language><publisher>Japan: The Japanese Circulation Society</publisher><subject>Administration, Oral ; Aged ; Anticoagulants - adverse effects ; Atrial Fibrillation - epidemiology ; Cause of Death ; Elderly ; Female ; Humans ; Japan ; Male ; Non-valvular atrial fibrillation ; Prospective Studies ; Real-world study ; Registries ; Risk Factors ; Stroke - etiology ; Treatment Outcome</subject><ispartof>Circulation Journal, 2023/06/23, Vol.87(7), pp.957-963</ispartof><rights>2023, THE JAPANESE CIRCULATION SOCIETY</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c494t-f33292329ae216fd7f9087447d82f11fb1916f92be1933506678e2cbcaee76693</citedby><cites>FETCH-LOGICAL-c494t-f33292329ae216fd7f9087447d82f11fb1916f92be1933506678e2cbcaee76693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36653127$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamashita, Takeshi</creatorcontrib><creatorcontrib>Akao, Masaharu</creatorcontrib><creatorcontrib>Atarashi, Hirotsugu</creatorcontrib><creatorcontrib>Ikeda, Takanori</creatorcontrib><creatorcontrib>Koretsune, Yukihiro</creatorcontrib><creatorcontrib>Okumura, Ken</creatorcontrib><creatorcontrib>Shimizu, Wataru</creatorcontrib><creatorcontrib>Suzuki, Shinya</creatorcontrib><creatorcontrib>Tsutsui, Hiroyuki</creatorcontrib><creatorcontrib>Toyoda, Kazunori</creatorcontrib><creatorcontrib>Hirayama, Atsushi</creatorcontrib><creatorcontrib>Yasaka, Masahiro</creatorcontrib><creatorcontrib>Yamaguchi, Takenori</creatorcontrib><creatorcontrib>Teramukai, Satoshi</creatorcontrib><creatorcontrib>Kimura, Tetsuya</creatorcontrib><creatorcontrib>Morishima, Yoshiyuki</creatorcontrib><creatorcontrib>Takita, Atsushi</creatorcontrib><creatorcontrib>Inoue, Hiroshi</creatorcontrib><title>Causes of Death in Elderly Patients With Non-Valvular Atrial Fibrillation ― Results From the ANAFIE Registry</title><title>Circulation Journal</title><addtitle>Circ J</addtitle><description>Background: Previous studies on mortality in atrial fibrillation (AF) included a limited number of elderly patients receiving direct oral anticoagulants (DOACs). This subanalysis of the ANAFIE Registry evaluated 2-year mortality according to causes of death of elderly non-valvular AF (NVAF) patients in the DOAC era.Methods and Results: The ANAFIE Registry was a multicenter prospective observational study. Mean patient age was 81.5 years and 57.3% of patients were male. Of the 32,275 patients completing the study, 2,242 died. The most frequent causes of death were cardiovascular (CV) death (32.4%), followed by infection (17.1%) and malignancy (16.1%). Incidence rates of CV-, malignancy-, and infection-related death were 1.20, 0.60, and 0.63 per 100 person-years, respectively. Patients aged ≥85 years showed increased proportions of non-CV and non-malignancy deaths and a decreased proportion of malignancy deaths compared with patients aged &lt;85 years. The incidence of death due to congestive heart failure/cardiogenic shock, infection, and renal disease was higher in patients aged ≥85 than those aged &lt;85 years. Compared with warfarin, DOACs were associated with a significantly lower risk of death by intracranial hemorrhage, ischemic stroke, and renal disease.Conclusions: This subanalysis described the mortality according to causes of death of Japanese elderly NVAF patients in the DOAC era. Our results imply that a more holistic approach to comorbid conditions and stroke prevention are required in these patients.</description><subject>Administration, Oral</subject><subject>Aged</subject><subject>Anticoagulants - adverse effects</subject><subject>Atrial Fibrillation - epidemiology</subject><subject>Cause of Death</subject><subject>Elderly</subject><subject>Female</subject><subject>Humans</subject><subject>Japan</subject><subject>Male</subject><subject>Non-valvular atrial fibrillation</subject><subject>Prospective Studies</subject><subject>Real-world study</subject><subject>Registries</subject><subject>Risk Factors</subject><subject>Stroke - etiology</subject><subject>Treatment Outcome</subject><issn>1346-9843</issn><issn>1347-4820</issn><issn>1347-4820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM1O3DAUhS3UCiiwZ1V52U2ofxI7Xo7ChB8hWlWlXVpO5obxyJMMtoM0u3kJXrB9kXqYKSyur3X8nSPrIHROyQVlBf_aWt8uLqrbjLGMCJofoGPKc5nlJSMfXu8iU2XOj9CnEBaEMEUKdYiOuBAFp0weo1VlxgABDx2-BBPn2PZ46mbg3Rp_N9FCHwP-bdPD_dBnv4x7Hp3xeBK9NQ7XtvHWucQN_d_N5s_mBf-AMLrkqf2wxHEOeHI_qW-mSX-0Ifr1KfrYGRfgbL9P0EM9_VldZ3ffrm6qyV3W5iqPWcc5UyyNAUZFN5OdIqXMczkrWUdp11CVZMUaoIrzggghS2Bt0xoAKYTiJ-jLLnflh6cRQtRLG1pIn-1hGINmUkgqykLQhJId2vohBA-dXnm7NH6tKdHbnvVrz7q61Yzpbc_J8nmfPjZLmL0Z_hebgHoHLEI0j_AGGB9t62CfWEott8d78jswN15Dz_8BeraUTQ</recordid><startdate>20230623</startdate><enddate>20230623</enddate><creator>Yamashita, Takeshi</creator><creator>Akao, Masaharu</creator><creator>Atarashi, Hirotsugu</creator><creator>Ikeda, Takanori</creator><creator>Koretsune, Yukihiro</creator><creator>Okumura, Ken</creator><creator>Shimizu, Wataru</creator><creator>Suzuki, Shinya</creator><creator>Tsutsui, Hiroyuki</creator><creator>Toyoda, Kazunori</creator><creator>Hirayama, Atsushi</creator><creator>Yasaka, Masahiro</creator><creator>Yamaguchi, Takenori</creator><creator>Teramukai, Satoshi</creator><creator>Kimura, Tetsuya</creator><creator>Morishima, Yoshiyuki</creator><creator>Takita, Atsushi</creator><creator>Inoue, Hiroshi</creator><general>The Japanese Circulation Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230623</creationdate><title>Causes of Death in Elderly Patients With Non-Valvular Atrial Fibrillation ― Results From the ANAFIE Registry</title><author>Yamashita, Takeshi ; Akao, Masaharu ; Atarashi, Hirotsugu ; Ikeda, Takanori ; Koretsune, Yukihiro ; Okumura, Ken ; Shimizu, Wataru ; Suzuki, Shinya ; Tsutsui, Hiroyuki ; Toyoda, Kazunori ; Hirayama, Atsushi ; Yasaka, Masahiro ; Yamaguchi, Takenori ; Teramukai, Satoshi ; Kimura, Tetsuya ; Morishima, Yoshiyuki ; Takita, Atsushi ; Inoue, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c494t-f33292329ae216fd7f9087447d82f11fb1916f92be1933506678e2cbcaee76693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Administration, Oral</topic><topic>Aged</topic><topic>Anticoagulants - adverse effects</topic><topic>Atrial Fibrillation - epidemiology</topic><topic>Cause of Death</topic><topic>Elderly</topic><topic>Female</topic><topic>Humans</topic><topic>Japan</topic><topic>Male</topic><topic>Non-valvular atrial fibrillation</topic><topic>Prospective Studies</topic><topic>Real-world study</topic><topic>Registries</topic><topic>Risk Factors</topic><topic>Stroke - etiology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamashita, Takeshi</creatorcontrib><creatorcontrib>Akao, Masaharu</creatorcontrib><creatorcontrib>Atarashi, Hirotsugu</creatorcontrib><creatorcontrib>Ikeda, Takanori</creatorcontrib><creatorcontrib>Koretsune, Yukihiro</creatorcontrib><creatorcontrib>Okumura, Ken</creatorcontrib><creatorcontrib>Shimizu, Wataru</creatorcontrib><creatorcontrib>Suzuki, Shinya</creatorcontrib><creatorcontrib>Tsutsui, Hiroyuki</creatorcontrib><creatorcontrib>Toyoda, Kazunori</creatorcontrib><creatorcontrib>Hirayama, Atsushi</creatorcontrib><creatorcontrib>Yasaka, Masahiro</creatorcontrib><creatorcontrib>Yamaguchi, Takenori</creatorcontrib><creatorcontrib>Teramukai, Satoshi</creatorcontrib><creatorcontrib>Kimura, Tetsuya</creatorcontrib><creatorcontrib>Morishima, Yoshiyuki</creatorcontrib><creatorcontrib>Takita, Atsushi</creatorcontrib><creatorcontrib>Inoue, Hiroshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamashita, Takeshi</au><au>Akao, Masaharu</au><au>Atarashi, Hirotsugu</au><au>Ikeda, Takanori</au><au>Koretsune, Yukihiro</au><au>Okumura, Ken</au><au>Shimizu, Wataru</au><au>Suzuki, Shinya</au><au>Tsutsui, Hiroyuki</au><au>Toyoda, Kazunori</au><au>Hirayama, Atsushi</au><au>Yasaka, Masahiro</au><au>Yamaguchi, Takenori</au><au>Teramukai, Satoshi</au><au>Kimura, Tetsuya</au><au>Morishima, Yoshiyuki</au><au>Takita, Atsushi</au><au>Inoue, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Causes of Death in Elderly Patients With Non-Valvular Atrial Fibrillation ― Results From the ANAFIE Registry</atitle><jtitle>Circulation Journal</jtitle><addtitle>Circ J</addtitle><date>2023-06-23</date><risdate>2023</risdate><volume>87</volume><issue>7</issue><spage>957</spage><epage>963</epage><pages>957-963</pages><artnum>CJ-22-0614</artnum><issn>1346-9843</issn><issn>1347-4820</issn><eissn>1347-4820</eissn><abstract>Background: Previous studies on mortality in atrial fibrillation (AF) included a limited number of elderly patients receiving direct oral anticoagulants (DOACs). This subanalysis of the ANAFIE Registry evaluated 2-year mortality according to causes of death of elderly non-valvular AF (NVAF) patients in the DOAC era.Methods and Results: The ANAFIE Registry was a multicenter prospective observational study. Mean patient age was 81.5 years and 57.3% of patients were male. Of the 32,275 patients completing the study, 2,242 died. The most frequent causes of death were cardiovascular (CV) death (32.4%), followed by infection (17.1%) and malignancy (16.1%). Incidence rates of CV-, malignancy-, and infection-related death were 1.20, 0.60, and 0.63 per 100 person-years, respectively. Patients aged ≥85 years showed increased proportions of non-CV and non-malignancy deaths and a decreased proportion of malignancy deaths compared with patients aged &lt;85 years. The incidence of death due to congestive heart failure/cardiogenic shock, infection, and renal disease was higher in patients aged ≥85 than those aged &lt;85 years. Compared with warfarin, DOACs were associated with a significantly lower risk of death by intracranial hemorrhage, ischemic stroke, and renal disease.Conclusions: This subanalysis described the mortality according to causes of death of Japanese elderly NVAF patients in the DOAC era. Our results imply that a more holistic approach to comorbid conditions and stroke prevention are required in these patients.</abstract><cop>Japan</cop><pub>The Japanese Circulation Society</pub><pmid>36653127</pmid><doi>10.1253/circj.CJ-22-0614</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1346-9843
ispartof Circulation Journal, 2023/06/23, Vol.87(7), pp.957-963
issn 1346-9843
1347-4820
1347-4820
language eng
recordid cdi_proquest_miscellaneous_2767168561
source MEDLINE; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Administration, Oral
Aged
Anticoagulants - adverse effects
Atrial Fibrillation - epidemiology
Cause of Death
Elderly
Female
Humans
Japan
Male
Non-valvular atrial fibrillation
Prospective Studies
Real-world study
Registries
Risk Factors
Stroke - etiology
Treatment Outcome
title Causes of Death in Elderly Patients With Non-Valvular Atrial Fibrillation ― Results From the ANAFIE Registry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T12%3A04%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Causes%20of%20Death%20in%20Elderly%20Patients%20With%20Non-Valvular%20Atrial%20Fibrillation%E3%80%80%E2%80%95%20Results%20From%20the%20ANAFIE%20Registry&rft.jtitle=Circulation%20Journal&rft.au=Yamashita,%20Takeshi&rft.date=2023-06-23&rft.volume=87&rft.issue=7&rft.spage=957&rft.epage=963&rft.pages=957-963&rft.artnum=CJ-22-0614&rft.issn=1346-9843&rft.eissn=1347-4820&rft_id=info:doi/10.1253/circj.CJ-22-0614&rft_dat=%3Cproquest_cross%3E2767168561%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2767168561&rft_id=info:pmid/36653127&rfr_iscdi=true